Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis: Sarcoma/Melanoma

Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas?

Franziska Walter, Noah Federman, Wipapat Apichairuk, Michael Phelps and Johannes Czernin
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1919;
Franziska Walter
1Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noah Federman
2Pediatrics, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wipapat Apichairuk
3Pathology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Phelps
1Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
1Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 1919

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Franziska Walter1,
  2. Noah Federman2,
  3. Wipapat Apichairuk3,
  4. Michael Phelps1 and
  5. Johannes Czernin1
  1. 1Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA
  2. 2Pediatrics, University of California Los Angeles, Los Angeles, CA
  3. 3Pathology, University of California Los Angeles, Los Angeles, CA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2015 to April 2025

AbstractFullPdf
Jun 2015800
Jul 2015200
Aug 2015100
Sep 2015400
Nov 2015100
Dec 2015100
Mar 2016200
Apr 2016300
Oct 2016200
Nov 2016200
Dec 2016100
Jan 2017100
Feb 2017100
Mar 2017100
Jun 2017200
Aug 2017100
Sep 2018300
Oct 2018200
Sep 2019100
Oct 2019100
Dec 2019100
Feb 2020400
Mar 20201500
Apr 2020800
Jun 2020100
Jul 2020400
Aug 20201400
Sep 20202200
Oct 20201000
Nov 20201400
Dec 2020600
Jan 2021200
Feb 20211200
Mar 20215800
Apr 20214300
May 20211200
Jun 2021300
Jul 20211200
Aug 20212400
Sep 20211000
Oct 2021900
Nov 20215400
Dec 20214000
Jan 20226800
Feb 20223600
Mar 20226200
Apr 20225500
May 20225400
Jun 20224300
Jul 20223800
Aug 20224300
Sep 20222700
Oct 20223600
Nov 20221200
Jan 2023100
Feb 2023100
Mar 2023100
May 2023200
Jun 2023400
Jul 2023100
Aug 2023300
Sep 2023100
Oct 2023200
Nov 2023300
Dec 2023400
Jan 2024200
Mar 2024200
Apr 2024400
May 2024500
Jun 2024400
Jul 2024100
Aug 2024500
Sep 2024400
Oct 2024300
Nov 2024500
Dec 2024400
Jan 2025200
Feb 2025200
Mar 2025100
Apr 2025400
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas?
Franziska Walter, Noah Federman, Wipapat Apichairuk, Michael Phelps, Johannes Czernin
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1919;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas?
Franziska Walter, Noah Federman, Wipapat Apichairuk, Michael Phelps, Johannes Czernin
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1919;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis: Sarcoma/Melanoma

  • FDG PET/CT of patients with melanoma: Clinical impact of imaging the lower extremities
  • Assessment of early response to neoadjuvant chemotherapy in osteosarcoma using parallely installed PET/CT-MRI: Prospective study
Show more Oncology: Clinical Diagnosis: Sarcoma/Melanoma

Sarcoma/Melanoma Posters

  • Prognostic value of post-treatment 18F-FDG PET/CT studies in melanoma patients receiving ipilimumab
  • Evaluate the cutoff value of 18F-FDG PET parameters to predict lymph node metastasis in the cutaneous melanoma.
  • Value of EORTC criteria in treatment monitoring of melanoma patients receiving ipilimumab
Show more Sarcoma/Melanoma Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire